相关实验视频
Updated: Jul 23, 2026

11:10
Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
2型糖尿病:病原和治疗的原理
Michael Stumvoll1, Barry J Goldstein, Timon W van Haeften
1Third Medical Department, University of Leipzig, Leipzig, Germany.
Lancet (London, England)
|April 13, 2005
概括
2型糖尿病是一种广泛的流行病. 本研究探讨了胰岛素抵抗和β细胞功能障碍的复杂机制,以及遗传因素和综合管理策略.
科学领域:
- 内分泌学和新陈代谢学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 2型糖尿病 (T2DM) 是一种全球流行病,其特点是胰岛素不敏感和渐进的β细胞功能障碍.
- 胰岛素抵抗与肥胖有关,而β细胞功能随着时间的推移而下降,先于高血糖症.
- 胰岛素抵抗的拟议机制包括高的非化脂肪酸,炎症性细胞因子,基因和线粒体功能障碍.
研究的目的:
- 阐明T2DM病原体背后的多方面的机制.
- 审查T2DM的遗传基础.
- 概述T2DM的当前和全面的管理方法.
主要方法:
- 关于胰岛素抵抗和β细胞功能障碍的拟议机制的文献综述.
- 已识别的导致T2DM的遗传因素的总结.
- 治疗策略的概述,包括生活方式,抗高血糖剂和支持性疗法.
主要成果:
- 胰岛素抵抗涉及诸如肥胖,脂肪酸,细胞因子,基因和线粒体问题等因素.
- 贝塔细胞功能障碍与葡萄糖毒性,脂毒性和粉样蛋白形成有关.
- 基因因素如CAPN10,KCNJ11,PPARG和IRS1在T2DM易感性中起作用.
结论:
- T2DM的发病因子是多因素的,包括胰岛素耐药性,β细胞衰竭和遗传倾向.
- 有效的管理需要生活方式修改和药理干预措施的结合.
- 对遗传成分和治疗点的进一步研究对于打击T2DM流行病至关重要.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

